CPT code 20974 covers the surgical placement of a device that delivers electrical impulses directly to a fracture site to promote bone healing. This procedure is clinically relevant for patients with delayed union or nonunion of fractures and represents a targeted adjunct to surgical fracture management. Nationally, use of implantable electrical bone growth stimulators affects post-operative care pathways and payer coverage decisions given device and procedural costs.

Key payers included in the discussion are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical indications and service setting, typical claims and billing considerations, common modifiers, and payer coverage patterns where available. The publication also summarizes benchmarks for utilization, identifies policy updates that influence reimbursement and prior authorization, and places the service in clinical context relative to alternative bone-healing therapies.

Data not available in the input for some fields is noted in the full content where applicable. The material is written for a national audience interested in clinical, billing, and policy aspects of implantable electrical bone growth stimulation represented by CPT code 20974.